iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis.

MLA

Einhaus, Jakob, et al. “INKT Cells Can Effectively Inhibit IL-6 Production by B Cells in Systemic Sclerosis.” Cytotherapy, vol. 24, no. 5, May 2022, pp. 482–88. EBSCOhost, https://doi.org/10.1016/j.jcyt.2021.12.002.

APA

Einhaus, J., Asteriti, E., Pecher, A.-C., Keppeler, H., Klein, R., Schneidawind, C., Henes, J., & Schneidawind, D. (2022). iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis. Cytotherapy, 24(5), 482–488. https://doi.org/10.1016/j.jcyt.2021.12.002

Chicago

Einhaus, Jakob, Elisa Asteriti, Ann-Christin Pecher, Hildegard Keppeler, Reinhild Klein, Corina Schneidawind, Joerg Henes, and Dominik Schneidawind. 2022. “INKT Cells Can Effectively Inhibit IL-6 Production by B Cells in Systemic Sclerosis.” Cytotherapy 24 (5): 482–88. doi:10.1016/j.jcyt.2021.12.002.